Host Defense and Vaccination
Immune System & Host Defense
- Primary function: Host defense.
- Revision of major concepts: major immune cells, major mediators, immune response to different pathogens, vaccines, and adjuvants.
Cells of the Immune System
- Innate System:
- Myeloid cells (e.g., neutrophils, macrophages).
- NK cells.
- Adaptive Immune System:
- Lymphocytes: T cells and B cells.
- Two systems must work together.
T Cell Activation Example
- Two signals needed for T cell activation.
- Signal 1: TCR (T cell receptor) signaling through recognition of cognate peptide presented by dendritic cells.
- Signal 2: CD28 on T cells engaging with co-stimulatory molecules (CD80 or CD86) on dendritic cells.
- Signal 2 is dependent on activation of the innate system.
- Innate system provides the second signal required for T cell activation.
Host-Pathogen Interaction
- Microbial entry, establishment of a niche, induction of host response, pathogen elimination or persistence (chronic infection).
- Acute infection example:
- Innate immune response: Rapid (seconds, minutes, hours).
- Recruitment of neutrophils and macrophages.
- Adaptive immune system: Complete control of infection; more sophisticated mechanisms to combat infection.
Viral/Bacterial Control Phases
- Early phase:
- Type I interferon, NK cells.
- Later phase:
- Effector lymphocytes (T cells, B cells).
- B cells produce antibodies to neutralize the virus.
- CD8 T cells kill infected cells.
- Innate and adaptive systems are complementary.
Innate System: Pattern Recognition Receptors (PRRs)
- Sensing molecules expressed where microbes may be present (cell surface, endosomal, cytosolic).
- Examples:
- Toll-like receptors (TLRs):
- Surface: TLR2, TLR4 (sense extracellular bacteria).
- Endosomal: TLR3, TLR8, TLR9 (sense viral infection).
Ligands Recognized by Sensing Molecules
- PAMPs: Pathogen-Associated Molecular Patterns (microbe-derived).
- DAMPs: Damage-Associated Molecular Patterns (host-derived).
- DAMPs are released by damaged cells during infection/inflammation, triggering inflammation.
Natural Killer (NK) Cells
- Innate lymphocytes that can kill infected cells.
- Produce inflammatory cytokines (interferon-gamma, TNF) to activate macrophages.
- Antibody-dependent cell-mediated cytotoxicity (ADCC): kill infected cells coated with antibodies via Fc receptor binding.
- Collaboration between adaptive and innate systems.
- Activated by classical, alternative, and lectin pathways.
- Mechanisms of action:
- Membrane attack complex (MAC) formation leads to lysis of infected cells.
- Release of cleaved components (C3a, C5a) triggers local inflammation and immune cell recruitment.
- Regulation of inflammation.
Adaptive System: B and T Cells
- B cells: antibody production.
- T cells:
- CD4 T cells (helper cells).
- CD8 T cells (cytotoxic T cells).
Immune Response to Pathogens
- Extracellular bacteria/pathogens:
- Humoral response (antibody-dependent control).
- Intracellular bacteria/parasites:
- Cell-mediated immunity.
- Pathogens reside inside phagocytes.
- Antibodies cannot penetrate cells.
- Some pathogens live in the cytoplasm or in vacuoles of phagolysosomes.
Antigen Processing and Presentation
- Endogenous antigens (cancer cells, viral infection):
- Processed and presented via MHC class I.
- Exogenous antigens:
- Presented via MHC class II.
- MHC class I presents peptides to CD8 T cells.
- MHC class II presents antigens to CD4 T cells.
- Differential location of pathogens triggers different T cell responses due to different MHC processing and presentation pathways.
Immunopathology
- Host response to microbes can cause tissue damage.
- Example: Immunopathology of COVID-19.
- Severe COVID: lymphocyte reduction (T and B cells), increased myeloid cells (neutrophils, macrophages, monocytes).
- Massive cytokine production (inflammatory cytokines).
- Increased antibody production.
- Motor organ inflammation with rare virus detection in inflamed tissues.
- Treatment: immunosuppression (e.g., anti-dexamethasone, anti-IL-6 receptor antibodies).
Characteristics of Adaptive Immunity
- Specificity and memory.
- Serum Antibody Data
- Primary response: first exposure to antigen X produces a relatively small anti-X response.
- Secondary response: second injection with antigens X and Y results in:
- Enhanced anti-X antibody production (faster and greater magnitude).
- Moderate anti-Y antibody production (primary response).
- Memory cells (T and B cells) mediate enhanced secondary response.
CD8+ T Cell Response
- Viral growth kinetics:
- Virus titer builds up quickly, peaks, and is eliminated by innate and adaptive immunity.
- CD8+ T cells peak after viral infection peak.
- Three phases of CD8+ T cell response:
- Expansion: rapid increase in CD8+ T cell number.
- Contraction: most cells die.
- Memory: few cells survive, providing long-lasting memory.
- Terminal effector T cells: expand dramatically but are eliminated after virus clearance.
- Memory cells: increase, but remain relatively stable, allowing for a stronger secondary response upon re-exposure.
Immunization
- Enhance immunity against infection.
- Two types of immunity:
- Active Immunity: host response to microbe or microbial antigen (e.g., vaccination).
- Exposure to infection or vaccination leads to memory cells.
- Re-EXposure to pathogen triggers recall response.
- Passive Immunity: adoptive transfer of antibodies or T cells.
- Serum collected from immune individuals/animals and transferred to another individual.
- Provides specificity but does not establish long-term memory.
Passive Immunity: Antibody Transfer
- Neutralizes toxins.
- Serum sickness: immune response against animal antibodies after repeated exposure.
- Solution: use human plasma or antigen-specific monoclonal human antibodies.
Mechanism of Transferred Antibody in Viral Infection
- Neutralize invading pathogens.
- Enhance uptake of virus via opsonization and phagocytosis.
- Activate complement cascade via the classical pathway.
- Bind to Fc receptor on NK cells, leading to killing of infected cells.
Adaptive Immunity and Vaccination Study (COVID-19)
- mRNA vaccines reduce viral incidence.
- Increased vaccination rate correlates to control of infection.
- Active immunity works better in younger individuals.
Vaccine Definition and Components
- Biological product that induces immune response to confer protection against infection/disease upon exposure to the same pathogen.
- Must contain antigens expressed by the pathogen.
- Clinical endpoint: protection against infection/disease severity.
- Immune correlates of protection: predict protection upon re-exposure.
Adjuvants
- Boost immune response, especially in recombinant vaccines.
- Essential in inducing primary T and B cell response.
- Many adjuvants are microbial products/PAMPs.
- Examples: alum, AS04 (modified LPS), CpG 118 (DNA from microbes).
- Activate innate immune response, upregulate co-stimulatory molecules (signal 2), and enhance T cell response.
- Increase immunogenicity of weak antigens.
- Enhance the speed and duration of immune response.
- Stimulate humoral and cell-mediated immune response.
Types of Vaccines
- RNA/DNA vaccine.
- Recombinant protein (protein + adjuvant).
- Viral vectors (adenovirus).
- Whole organism vaccines:
- Inactivated vaccines (killed pathogens).
- Live attenuated vaccines (weakened organisms).
COVID-19 Vaccines
- RNA vaccine.
- Viral vectors.
- Whole virus (inactivated).
- Protein subunit.
mRNA Vaccine Mechanism
- Spike protein construct in lipid nanoparticles.
- Cells uptake the construct and produce spike protein.
- Spike protein expressed on cell surface interacts with B cells.
- Spike protein picked up by dendritic cells, migrate to the lymph nodes.
- CD8 and CD4 T cells are activated.
- CD4 T cells differentiate into TFH cells, promote B cell activation and antibody production.
Summary
- Host defense against infection is the primary function of the immune system.
- Mediated by both innate and adaptive immunity.
- Different effective mechanisms control different types of microbes.
- Host response can sometimes cause disease (immunopathology).
- Vaccines save lives.